Staar Surgical (NSDQ:STAA) today said it has appointed Patrick Williams as chief financial officer, effective immediately.
Williams will report directly to the president and CEO Caren Mason. His appointment is part of a planned transition following Deborah Andrews’s retirement.
“STAAR is pleased to have a financial leader of Patrick’s caliber join the team at a time of such significant global opportunity for our EVO family of lenses,” Mason said in a news release. “Patrick has an impressive record of success in executive leadership roles in medical devices. His financial and operational experience in leading consumer-facing and marketing focused medical device companies makes him well suited to join STAAR. He has demonstrated a track record of success in significantly growing revenue and shareholder value.”
Williams has more than 20 years of experience in financial and operational management with public companies. He most recently served as chief financial officer and general manager of the miraDry business unit at Sientra. Prior to Sientra, Williams was chief financial officer of Zeltiq Aesthetics. He has also held a number of leadership roles at NuVasive.
“I am incredibly excited to join STAAR. The Company has a unique opportunity to accelerate an already impressive growth trajectory and become the refractive procedure of choice for ophthalmic surgeons and patients around the world. I look forward to working with Caren, the STAAR team and applying my experience and deep understanding in building growth medical device companies to accomplish this goal,” Williams said. “I thank Deborah for continuing to work with STAAR in an advisory role to ensure a smooth transition of responsibilities to Patrick. She is leaving behind a strong global finance and accounting team and we are grateful for all her contributions to STAAR over a 25-year career. We wish Deborah a wonderful retirement and all the best in her future endeavors.”